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Results: Cartilage cultured in the presence of blood showed a decrease
of proteoglycan synthesis rate of 70%, an increase of proteoglycan release
of 100%, and a decrease of proteoglycan content of 15% after 16 days of
culture (all p<0.05). This blood-induced damage of the cartilage matrix
was limited by IL-4 in a clear dose-dependent way. Addition of 100 ng/ml
IL-4 during blood-exposure reduced the proteoglycan synthesis rate with
only 45%, and decreased the proteoglycan release with 30% compared
to control (all p<0.05). Moreover, proteoglycan content was normalized.
The combination of IL-4 and IL-10 was clearly more protective against
damage caused by blood. This was especially evident for the proteoglycan
synthesis which was completely normalized. Furthermore, treatment with
a combination of the two cytokines was signiﬁcantly better than the effect
of IL-4 and IL-10 alone (p<0.05).
Conclusions: Besides IL-10, as shown previously, also IL-4 protects against
blood-induced cartilage damage. The combination of these two cytokines
is clearly the most protective. In addition to the direct effects on cartilage,
both cytokines are synergistic in inhibition of inﬂammation. As such,
this justiﬁes further evaluation of the combination of IL-4 and IL-10 in
prevention and treatment of blood-induced joint damage.
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BRADYKININ, THROUGH B2 RECEPTORS, ACTIVATES THE RELEASE OF THE
CYTOKINE INTERLEUKIN 6, THE CHEMOKINE INTERLEUKIN 8, AND THE
METALLOPROTEINASE 3 IN HUMAN KNEE CHONDROCYTES
S. Meini, P. Cucchi, F. Bellucci, C. Catalani, S. Giuliani, C.A. Maggi
Menarini Ricerche S.p.A., Florence, Italy
Purpose: Bradykinin (BK, H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH) is a
proinﬂammatory and algogenic peptide: it releases inﬂammatory media-
tors and sensitizes sensory afferents through the activation of B2 receptors
expressed on the membrane of several cell types, including synoviocytes
and chondrocytes. Aim of the current investigation was to investigate if BK
and B2 receptor can participate into mechanisms which are involved into
ostearthritis (OA) degenerative events, and to evaluate the possibility to
prevent them through B2 receptor blockade, using the highly selective and
potent B2 receptor antagonist MEN16132 (m.w. 873.16).
Methods: Human chondrocytes (Lonza, CC-2550) were cultured in
F12/DMEM 1:1 added with CGM Singlequots (Lonza, CC-4409) and Gln
2mM and used up to ﬁfth passage. Experiments were performed with
cells at conﬂuence plated onto 24-well plates. Cells were incubated at
the indicated concentration of BK in F12 medium supplemented with
foetal bovine serum (1%), penicillin (50 μg/ml), streptomycin (50 μg/ml),
amphotericin B (0.75 μg/ml), Gln (2 mM), and captopril (1 μM). At the
end of the experiments, surnatants were collected and stored at -80°C
and used for the dosage of interleukin 6 (IL-6), interleukin 8 (IL8), and
metalloproteinase 3 (MMP3). IL-6, IL-8, and MMP3 contents in the super-
natant were assayed by commercially available enzyme immunoassay kits
(Promokine PK-EL-61606, PK-EL-61806, and Biosource KAC1541). Data are
expressed as mean ± s.e.m. or 95% conﬁdence limits in parentheses of 3 to
5 experiments, each in triplicate.
Results: Time-course experiments (2 - 96 h) indicated that BK (1 μM)
induced a release of IL-6, IL-8, and MMP3 which increased over the time,
stably peaked after 24 h of incubation, and remained constant up to 96
h. The maximal production of IL-6, IL-8 and MMP3 induced by BK (24 h
incubation) was 557±39 pg/ml, 1267±169 pg/ml, and 5.52±0.73 ng/ml,
respectively and was resembling that induced by the pleiotropyc cytokine
TNFα (0.1 ng/ml)(817±350 pg/ml, 1778±198 pg/ml, and 1.96±0.2 ng/ml,
respectively). Concentration-response curves to BK (0.1 nM - 1 μM, 24 h)
indicated EC50 values of 10 nM (5.4-18.6) in inducing an augmented release
of IL-6, 9.7 nM (3.7-32.5) for the release of IL-8, and 9.1 nM (1.1-7.6) for
MMP3 secretion. This effect provoked by BK (100 nM, submaximal concen-
tration) were concentration-dependently prevented by the pretreatment
of HCCK (30 min) with the selective B2 receptor antagonist MEN16132,
and IC50 values were 1.7 nM (1.0-2.8) to inhibit IL-6 production, 2.2 nM
(0.7-7.1) for IL-8, and 0.7 nM (0.3-1.4) for inhibition of MMP3 secretion.
Conclusions: These ﬁndings disclose novel actions of BK that imply its pos-
sible involvement in joint degenerative diseases, and indicate B2 receptor
blockade as a potential therapy in OA pathology.
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CARTILAGE THICKENING IN EARLY RADIOGRAPHIC KNEE
OSTEOARTHRITIS - FACT OR ARTIFACT?
S. Cotofana1, W. Wirth1, R.J. Buck2, F. Roemer3, D. Dreher4, M. Nevitt5,
F. Eckstein1
1PMU-Salzburg, Salzburg, Austria; 2StatAnswers Consulting LLC, San Diego, CA;
3Quantitative Imaging Ctr., Dept. of Radiology, Boston, MA; 4Merck Serono,
Geneva, Switzerland; 5UCSF, San Francisco, CA
Purpose: In animal studies of osteoarthritis (OA), increases in cartilage
thickness have been observed at the early phases, due either to cartilage
hypertrophy or edema. Evidence for cartilage thickening in human OA,
however, remains enigmatic. Cross sectional analyses and one longitudinal
study in human with MRI have indicated that medial osteophytes, in the
absence of medial joint space narrowing (JSN), may be associated with
cartilage thickening in the medial femorotibial compartment in human OA,
particularly in the external aspect of the medial femoral condyle (ecMF).
However, comparisons may have been confounded by differences in age,
BMI and other factors.
To eliminate confounding by between-person differences and to enhance
sensitivity, we performed a within-person between-knee analysis of carti-
lage thickness in knees with unilateral osteophytes and without JSN. The
primary endpoint was the between-knee cartilage thickness differences
in ecMF (in subjects with unilateral medial osteophytes), the secondary
endpoint was thickness differences in the external lateral femur (in those
with unilateral lateral osteophytes), and the exploratory endpoints were
thickness differences in all other femorotibial subregions.
Methods: 83 OA Initiative participants were selected from 4800 cases
(public use data sets 0.E.1 [imaging] and 0.2.2 [clinical]), who displayed
deﬁnite osteophytes and no JSN in one knee and no signs of radiographic
OA in the other knee, according to the site readings. The radiographs
were reviewed by a central reader (F.R.) and 61 participants were in-
cluded. Cartilage thickness was measured in four femorotibial cartilage
plates (medial/lateral, femur/tibia) and in 16 femorotibial subregions, using
sagittal DESSwe MR images and dedicated software (Chondrometrics).
Within-person between-knee differences were calculated with a paired
t-test and general linear models. No adjustment for multiple comparisons
was performed.
Results: Of the 61 participants (age 60.8±9.6 yrs; 29m/32f; BMI 27.8±4.7)
48% displayed medial, 36% lateral, and 16% bicompartimental (mostly tibial)
osteophytes. Knees with osteophytes had thicker cartilage than contralat-
eral knees in the external medial (ecMF:+5.5%,p=0.02) and external lateral
femur (ecLF:+4.1%,p=0.01), but in no other subregions. Knees with only
medial osteophytes displayed greater thickening in ecMF (+7.8%) than ecLF
(-0.1%), those with only lateral osteophytes greater thickening in ecLF
(+5.0%) than in ecMF (+1.7%), and those with bicompartimental osteophytes
similar thickening in both subregions (+17%/+15%, respectively). There was
no signiﬁcant effect of age, sex, or BMI on between-knee differences.
Conclusions: Knees with early radiographic OA (deﬁnite osteophytes, no
JSN) displayed thicker cartilage than the contralateral knees without radio-
graphic OA. The differences were speciﬁc to external medial femoral and
external lateral femoral subregions and appeared to be locally mediated by
(tibial) osteophytes in the same compartment.
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SUPEROXIDE DISMUTASE 2 DOWNREGULATION AND MITOCHONDRIA
RESPIRATION IN OSTEOARTHRITIS
C. Gabrielides1 , J.L. Scott1, R.W. Taylor2, D.A. Young1
1Musculoskeletal Res. Group, Inst. of Cellular Med., Newcastle Univ., Newcastle
Upon Tyne, United Kingdom; 2Inst. for Ageing and Hlth., Newcastle Univ.,
Newcastle Upon Tyne, United Kingdom
Purpose: Oxidative phosphorylation takes place at the mitochondrial res-
piratory chain and is the major source for the production of ATP. A
by-product of this respiration are reactive oxygen species (ROS). ROS are
involved in signalling processes but when at high levels contribute to
oxidative damage. The major ROS include superoxide (O2•–) and hydrogen
peroxide (H2O2). The mRNA and protein levels of the major inhibitor of
superoxides in the mitochondria, superoxide dismutase 2 (SOD2), have
been shown to be downregulated in osteoarthritic compared to healthy
joint cartilage.
This study characterises the effects of reduced levels of SOD2 on chondro-
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cyte mitochondria as well as the effect on signalling pathways leading to
altered collagenase expression.
Methods: RNA intereference was used to characterise whether the reduc-
tion of SOD2 levels affects matrix metalloproteinase (MMP)-1 and MMP-13
gene expression along with superoxide levels produced by the mitochon-
dria in human articular chondrocytes (HAC). For the MMP-1 and MMP-13
expression, cells were then serum starved for 24 hours and stimulated
with IL-1. MMP-1 and MMP-13 mRNA levels were determined by real-time
RT-PCR. To assess the levels of superoxide and SOD2 protein, HAC were
stained with MitoSOX™ -Red, a speciﬁc indicator for superoxide in the
mitochondria, or an anti-SOD2 antibody. To compare the mitochondrial
respiratory activity between HAC from healthy patients (neck of femur
fractures, NOF) and from osteoarthritic patients (OA), cells were cultured
for 3 days after extraction from the cartilage and analysed for respiratory
activity using the Oroboros Oxygraph-2k respirometry system.
Results: SOD2 depletion by RNA interference led to a signiﬁcant decrease
in basal MMP-1 mRNA expression and a signiﬁcant reduction in the level
of MMP-1 and MMP-induction following IL-1 stimulation. SOD2 depletion
by RNA interference also led to a signiﬁcant increase in mitochondrial
superoxide levels.
In terms of respiratory capacity, OA chondrocytes have on average 65%
higher respiratory chain capacity than NOF chondrocytes. However, al-
though OA chondrocytes have a more active respiratory chain, it appears
less eﬃcient (25%) to that of HAC from NOF patients.
Conclusions: Depletion of SOD2 in OA chondrocytes leads to a signiﬁcant
decrease in the expression levels of the collagenases MMP-1 and MMP13,
indicating that the decrease of SOD2 expression in OA cartilage may rep-
resent a chondroprotective mechanism. However, this depletion leads to a
signiﬁcant increase of mitochondrial superoxide levels. Combined with the
increased levels of unutilised protons and electrons in the respiratory chain,
these effects can potentially alter the mitochondrial membrane potential of
the cells causing cellular dysfunction.
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GLATIRAMER ACETATE (GA), A PEPTIDE IMMUNOMODULATORY DRUG,
INHIBITS INFLAMMATORYMEDIATORS, MMP-13 ACTIVITY AND
COLLAGEN DEGRADATION IN OA CARTILAGE
M. Attur, J. Millman, M. Dave, H. Al-Mussawir, J. Patel, G. Palmer,
S.B. Abramson
NYUHosp. for Joint Diseases, New York, NY
Purpose: Glatiramer acetate (GA), the generic name for Copaxone, is an
immunomodulatory agent used in the treatment of multiple sclerosis,
which has been to shown to induce interleukin-1 receptor antagonist (IL-
1Ra) production in macrophages and microglial cells. In osteoarthritis, the
production of inﬂammatory mediators, particularly IL-1 by chondrocytes,
may be important in the pathogenesis and progression of OA. We therefore
tested the effects of GA on the catabolic activities of chondrocytes in OA
cartilage explants cultures.
Methods: Cartilage slices were obtained from the knees of patients with
advanced OA and undergoing knee replacement surgery. Non-arthritic
knee cartilages were obtained from autopsy patients within 24h (NDRI,
Philadelphia). Matrix metalloproteinases proMMP-13 ELISA kits were from
R&D Systems, (Minneapolis, MN). Predesigned TaqMan PCR primers were
purchased from Applied Biosystems (CA).
Results: We have previously shown that OA cartilage explant cultures
spontaneously release inﬂammatory mediators such as nitric oxide,
Prostaglandin E2 (PGE2), interleukins including IL-1betaand matrix metal-
loproteinases (MMPs). In this study we evaluated the chondroprotective
property of GA in monolayer cultures of primary OA chondrocytes and
cartilage explant cultures. GA (5-100ug/ml) treatment dose dependently
increased transcription (QPCR) and production (ELISA) of sIL-1Ra (p>0.001)
in normal and OA Chondrocytes. GA also intrinsically increased (p<0.001)
sIL-1Ra production by OA cartilage explant cultures. Furthermore, addition
of GA: 1) inhibited both spontaneous and IL-1 induced inﬂammatory
mediators such as nitric oxide (NO) (9.0+1.5 to 1.5+0.5 uM; p<0.01)
and PGE2 (100.6+18.5 to 15.1+6.1 ng/ml; p<0.01) production; 2) inhib-
ited spontaneous and IL-1 induced proMMP-13 secretion (200.6+90.5 to
78.5+15.1ng/ml; p<0.001); 3) inhibited APMA activated total MMP-13
activity by more than 30-50% (p<0.01); 4) inhibited collagen degradation
as assayed by CTXII ELISA (17.4+1.7 to 4.5+1.9 ng/ml; p<0.01). All these
chondroprotective effects of GA were dose dependent and signiﬁcance was
reached between 10-100 ug/ml.
Conclusion: Glatiramer acetate is a complex heterogeneous mixture of
polypeptides that exhibits “chondroprotective” properties in OA cartilage,
inhibiting the production of inﬂammatory mediators as well as MMP-13
expression/activation. The data suggest that these effects may be due
to upregulation of IL-1Ra. Based on these studies, we propose that GA
may have potential for disease modifying properties in OA and should be
evaluated in vivo animal studies.
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ADIPONECTIN AND LEPTIN EXHIBIT DIFFERENT PATTERN OF
PRODUCTION IN CARTILAGE FROM PATIENTS WITH OSTEOARTHRITIS
P.-J. Francin, C. Guillaume, P. Gegout-Pottie, P. Netter, D. Mainard, N. Presle
UMR 7561 CNRS-Nancy Univ., Vandoeuvre les Nancy, France
Purpose. Based on the association between obesity and osteoarthritis (OA),
increasing studies aimed to determine the contribution of adipokines in
OA. As adiponectin and leptin may exhibit opposite inﬂammatory effects
and display different patterns of distribution between the joint and the
circulating compartment, we compared the production of both adipokines
in cartilage from human OA-affected joints in relation with the grade of
cartilage destruction and with the Body Mass Index (BMI) of the patients.
Methods. The production of leptin and adiponectin was determined by
ELISA in conditioned media from cultured full-depth cartilage biopsies
obtained from patients with OA. The severity of OA cartilage lesion was
then evaluated after histological analysis of each specimen and was graded
using the Mankin score.
Results. The results indicated that the production of adiponectin in OA
cartilage are quite different from that of leptin. A positive association has
been found between the BMI of the patients and the production level of
leptin while the synthesis of adiponectin did not change with the BMI.
In addition, a grade-dependent increase in the production level of leptin
was shown for non obese patients (BMI<30kg/m2). The synthesis of leptin
strongly increased in obese patients (BMI>30kg/m2) between the low and
the moderate OA grades, but did not change anymore for the most severe
OA grade. The adiponectin production was slightly elevated in cartilage
samples with moderate or advanced OA compared to specimens with low
histological OA score, but the difference did reach statistical signiﬁcance.
Conclusion. These ﬁndings indicated that leptin and adiponectin exhibit
different pattern of production in OA cartilage. The leptin level is strongly
associated with both the grade of cartilage destruction and the BMI of the
patients. Conversely, the production of adiponectin is slightly up-regulated
in damaged cartilage independently of the OA score and the BMI of the
patients.
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WNT3A MODULATES CHONDROCYTE PHENOTYPE THROUGH ACTIVATION
OF BOTH CANONICAL AND NON-CANONICAL PATHWAYS
G. Nalesso1 , P. Achan2, C. Pitzalis1, F. Dell’Accio1
1Ctr. for Experimental Med. and Rheumatology, William Harvey Res. Inst.,
Barts and the London Sch. of Med. and Dentistry, London, United Kingdom;
2Dept. of Orthopaedics, Barts and the Royal London Hosp., London, United
Kingdom
Purpose: Injury to the articular cartilage results in the activation of Wnt sig-
nalling which may represent a homeostatic mechanism. Indeed disruption
of Wnt signalling results in osteoarthritis both in humans and experimental
models. Wnt ligands are traditionally categorized based on their capacity
to activate either the β-catenin-dependent canonical pathway or any of the
non canonical pathways including the Ca2+/Calmodulin-dependent kinase II
(CaMKII)-dependent or the PKA-dependent pathways, the planar cell polar-
ity pathway and the Wnt/ROR-mediated pathway. The clear-cut separation
between canonical and non-canonical Wnts has been recently challenged
and therefore the purpose of the study was to investigate through which
pathway Wnt3a modulates the cartilage phenotype and regulates cartilage
homeostasis in human articular chondrocytes.
Methods: Primary adult human articular chondrocytes were isolated from
preserved areas of the cartilage of patients undergoing knee arthroplasty
for osteoarthritis. Detection of protein and protein phosphorylation upon
Wnt3a stimulation was evaluated by western blotting. Intracellular calcium
mobilization was detected by cellular accumulation of FURA-4 dye. The
activation of the canonical pathway upon Wnt3a stimulation was evaluated
